Business Standard

Monday, December 23, 2024 | 10:35 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covishield safe, Covid-19 vaccination drive to go on with vigour: Govt

Top WHO official calls blood clots in AstraZeneca jab 'very rare'

covid vaccine
Premium

The UN health agency and the EMA are investigating the possibility of a link between blood clots and the AstraZeneca shots

Sohini DasRuchika Chitravanshi Mumbai/New Delhi
Even as concerns rise across the globe on the safety of the AstraZeneca-Oxford vaccine, India has found it safe, saying the nationwide inoculation drive can continue. The AstraZeneca-Oxford vaccine — called Covishield in India — is manufactured in the country by Pune-based Serum Institute of India, the world’s largest vaccine maker by volume. 

A senior member of the national Adverse Events Follo­wing Immunisation (AEFI) committee said that of the 38 autopsy reports they have studied of people who died after vaccination, they found nothing to link the deaths or adverse events to vaccination. “There are 71 deaths. We have received 38

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in